BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28510570)

  • 1. BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses.
    Papadakis ES; Reeves T; Robson NH; Maishman T; Packham G; Cutress RI
    Br J Cancer; 2017 Jun; 116(12):1585-1594. PubMed ID: 28510570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer.
    Nadler Y; Camp RL; Giltnane JM; Moeder C; Rimm DL; Kluger HM; Kluger Y
    Breast Cancer Res; 2008; 10(2):R35. PubMed ID: 18430249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast.
    Millar EK; Anderson LR; McNeil CM; O'Toole SA; Pinese M; Crea P; Morey AL; Biankin AV; Henshall SM; Musgrove EA; Sutherland RL; Butt AJ
    Br J Cancer; 2009 Jan; 100(1):123-33. PubMed ID: 19066611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bag-1 stimulates Bad phosphorylation through activation of Akt and Raf kinases to mediate cell survival in breast cancer.
    Kizilboga T; Baskale EA; Yildiz J; Akcay IM; Zemheri E; Can ND; Ozden C; Demir S; Ezberci F; Dinler-Doganay G
    BMC Cancer; 2019 Dec; 19(1):1254. PubMed ID: 31883527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma.
    Davidson B; Valborg Reinertsen K; Trinh D; Reed W; Bøhler PJ
    Hum Pathol; 2016 Aug; 54():64-73. PubMed ID: 27038683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAG-i expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data.
    Townsend PA; Dublin E; Hart IR; Kao RH; Hanby AM; Cutress RI; Poulsom R; Ryder K; Barnes DM; Packham G
    J Pathol; 2002 May; 197(1):51-9. PubMed ID: 12081204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines.
    Takayama S; Krajewski S; Krajewska M; Kitada S; Zapata JM; Kochel K; Knee D; Scudiero D; Tudor G; Miller GJ; Miyashita T; Yamada M; Reed JC
    Cancer Res; 1998 Jul; 58(14):3116-31. PubMed ID: 9679980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.
    O'Driscoll L; Linehan R; M Kennedy S; Cronin D; Purcell R; Glynn S; W McDermott E; D Hill A; J O'Higgins N; Parkinson M; Clynes M
    Cancer Lett; 2003 Nov; 201(2):225-36. PubMed ID: 14607338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAG-1 proteins protect cardiac myocytes from simulated ischemia/reperfusion-induced apoptosis via an alternate mechanism of cell survival independent of the proteasome.
    Townsend PA; Cutress RI; Carroll CJ; Lawrence KM; Scarabelli TM; Packham G; Stephanou A; Latchman DS
    J Biol Chem; 2004 May; 279(20):20723-8. PubMed ID: 14978028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of expression and polymorphism of the BAG-1 gene in response to platinum-based chemotherapeutics in NSCLC.
    Wang YD; Ha MW; Cheng J; Zhang WL; Cong X; Tong CY; Sun J
    Oncol Rep; 2012 Apr; 27(4):979-86. PubMed ID: 22179630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription.
    Cutress RI; Townsend PA; Sharp A; Maison A; Wood L; Lee R; Brimmell M; Mullee MA; Johnson PW; Royle GT; Bateman AC; Packham G
    Oncogene; 2003 Aug; 22(32):4973-82. PubMed ID: 12902980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAG-1: a novel biomarker predicting long-term survival in early-stage breast cancer.
    Turner BC; Krajewski S; Krajewska M; Takayama S; Gumbs AA; Carter D; Rebbeck TR; Haffty BG; Reed JC
    J Clin Oncol; 2001 Feb; 19(4):992-1000. PubMed ID: 11181661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review.
    de Ruijter TC; van der Heide F; Smits KM; Aarts MJ; van Engeland M; Heijnen VCG
    Breast Cancer Res; 2020 Jan; 22(1):13. PubMed ID: 32005275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression.
    Alford SH; Toy K; Merajver SD; Kleer CG
    Breast Cancer Res Treat; 2012 Apr; 132(2):429-37. PubMed ID: 21614565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.
    Hu Z; Huang G; Sadanandam A; Gu S; Lenburg ME; Pai M; Bayani N; Blakely EA; Gray JW; Mao JH
    Breast Cancer Res; 2010; 12(2):R18. PubMed ID: 20211017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma.
    Tang SC; Beck J; Murphy S; Chernenko G; Robb D; Watson P; Khalifa M
    Breast Cancer Res Treat; 2004 Apr; 84(3):203-13. PubMed ID: 15026618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of BAG-1 expression alters the sensitivity of breast cancer cells to tamoxifen.
    Liu H; Lu S; Gu L; Gao Y; Wang T; Zhao J; Rao J; Chen J; Hao X; Tang SC
    Cell Physiol Biochem; 2014; 33(2):365-74. PubMed ID: 24557447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
    Habibi G; Leung S; Law JH; Gelmon K; Masoudi H; Turbin D; Pollak M; Nielsen TO; Huntsman D; Dunn SE
    Breast Cancer Res; 2008; 10(5):R86. PubMed ID: 18925950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of BAG-1 protein correlates with aggressive behavior of prostate cancers.
    Krajewska M; Turner BC; Shabaik A; Krajewski S; Reed JC
    Prostate; 2006 Jun; 66(8):801-10. PubMed ID: 16482527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.